What is DSIP?
DSIP (Delta Sleep–Inducing Peptide) is a synthetic research peptide studied for its role in neurochemical signalling and circadian-related processes. In controlled laboratory environments, the DSIP peptide is explored for its interaction with sleep–wake regulation, stress response pathways, and neuroendocrine signalling. Lazarus Labs supplies DSIP in Australia in a high-purity, lyophilised 10MG format, ensuring stability and reproducibility for advanced peptide research applications.
Why researchers choose Lazarus Labs
Each batch of DSIP is manufactured in a GMP-compliant, ISO-certified facility and independently validated via HPLC and LC-MS analysis, with a certificate of analysis available for every batch. With ≥ 99 % verified purity, Lazarus Labs peptides deliver dependable quality and consistent molecular integrity for researchers across Australia.
Product highlights
- Total Concentration: 10MG per vial
- Purity: ≥ 99 % (independently verified)
- Solubility: Fully soluble in water (H₂O)
- Manufacturing: GMP + ISO 9001:2008 compliant
- Use: Designed for neurochemical and peptide-signalling research
- Form: White lyophilised powder for optimal stability
Handling & storage
Store sealed and dry at 2–8 °C. Follow your internal laboratory handling and stability procedures after preparation.
